客服热线:18202992950

Magnetic resonance imaging contrast agent and a process for the preparation thereof 发明授权

2023-03-23 3260 1770K 0

专利信息

申请日期 2025-07-07 申请号 KR1020110002331
公开(公告)号 KR101239130B1 公开(公告)日 2013-02-25
公开国别 KR 申请人省市代码 全国
申请人 KOREA INSTITUTE OF RADIOLOGICAL MEDICAL SCIENCES
简介 PURPOSE : An MRI contrast agent containing a compound is provided to lower cytotoxicity in vivo and to monitor various diseases and treatment process. CONSTITUTION : An MRI contrast compound is denoted by chemical formula 1. In chemical formula 1, M1 is Re^+, Re(CO)_3^+, CpRe(CO)_3^+, Re^3+, or ReO^3+. A method for preparing the compound comprises : a step of adding rhenium ion compounds to a gadolinium complex of DTPA-bis-amide-histidine ligand of chemical formula 4 to prepare a mixture solution; a step of adding methanol, ethanol, or acetone to the mixture solution and precipitating; and a step of isolating and drying the precipitate. The rhenium ion compound is [Et_4N]_2[ReBr_3CO_3] or Re(metal).


您还没有登录,请登录后查看下载地址


反对 0举报 0 收藏 0 打赏 0评论 0
下载排行
网站首页  |  关于我们  |  联系方式  |  使用协议  |  版权隐私  |  网站地图  |  排名推广  |  广告服务  |  积分换礼  |  网站留言  |  RSS订阅  |  违规举报  |  京ICP备2021025988号-4